FDA recall D-392-2014

Teva Pharmaceuticals USA · Class II · drug

Product

Daunorubicin Hydrochloride Injection, 20 mg/4 mL (5 mg/mL), 4 mL Single Dose Vial, Rx ONLY, For IV Use Only, Manufactured By: Teva parenteral Medicines, Inc., Irvine, CA NOVAPlus¿¿ labels. NDC 0703-5233-13 (carton), NDC 0703-5233-11 (vial) or NDC 0703-5233-93 (carton), NDC 0703-5233-91 (vial)

Reason for recall

Presence of Precipitate; precipitation of drug product

Distribution

Nationwide

Key facts

Status
Terminated
Initiation date
2013-10-11
Report date
2014-01-08
Termination date
2014-08-27
Voluntary/Mandated
Voluntary: Firm initiated
Location
Horsham, PA, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-392-2014